Skip to Main Content

Paper Details

FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma.
Clin Cancer Res
13
2021
E545K, E545K PIK3CA, EGFR, Epithelial-like Cutaneous Carcinoma, FGFR, GefR cSCC-PDXs, Gefitinib, PDX, PDXs, PIK3CA, PIK3CA-mutated tumors, RAS mutations, RNA, cSCC, cSCC-, cSCCs, cutaneous squamous cell carcinomas, gefitinib, gefitinib-resistant (GefR) cSCC-PDXs, mesenchymal-, mesenchymal-like cSCCs, patient, patients, primary cell cultures, tumor, tumor cell, tumors

Datasets